calpain has been researched along with Dementia* in 2 studies
1 review(s) available for calpain and Dementia
Article | Year |
---|---|
Involvement of calpain in the neuropathogenesis of Alzheimer's disease.
Alzheimer's disease (AD) is the most common (60% to 80%) age-related disease associated with dementia and is characterized by a deterioration of behavioral and cognitive capacities leading to death in few years after diagnosis, mainly due to complications from chronic illness. The characteristic hallmarks of the disease are extracellular senile plaques (SPs) and intracellular neurofibrillary tangles (NFTs) with neuropil threads, which are a direct result of amyloid precursor protein (APP) processing to Aβ, and τ hyperphosphorylation. However, many indirect underlying processes play a role in this event. One of these underlying mechanisms leading to these histological hallmarks is the uncontrolled hyperactivation of a family of cysteine proteases called calpains. Under normal physiological condition calpains participate in many processes of cells' life and their activation is tightly controlled. However, with an increase in age, increased oxidative stress and other excitotoxicity assaults, this regulatory system becomes impaired and result in increased activation of these proteases involving them in the pathogenesis of various diseases including neurodegeneration like AD. Reviewed here is a pool of data on the implication of calpains in the pathogenesis of AD, the underlying molecular mechanism, and the potential of targeting these enzymes for AD therapeutics. Topics: Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Calpain; Dementia; Humans; Lysosomes; Mice; Neurodegenerative Diseases; Neurofibrillary Tangles; Oxidative Stress; Phosphorylation; Plaque, Amyloid; Signal Transduction; Synapses | 2019 |
1 other study(ies) available for calpain and Dementia
Article | Year |
---|---|
FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion.
Frontal temporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17) is caused by splice site and missense mutations in the tau gene, and characterized by the accumulation of filamentous tau in cerebral neurons and glia. The missense mutations reduce the ability of tau to promote microtubule assembly and increase the ability of tau to form filaments. In this report we demonstrate that mutants V337M and R406W are less susceptible than mutant P301L or corresponding wild type tau to degradation by calpain I. The differences were at least in part due to changes in accessibility of a cleavage site located about 100 amino acids off the carboxy-terminus. The results suggest that the pathogenesis of some forms of FTDP-17 may involve tau accumulation due to decreased proteolytic degradation. Topics: Calpain; Chromosomes, Human, Pair 17; Dementia; Frontal Lobe; Humans; Immunoblotting; Kinetics; Mutation; Parkinsonian Disorders; Recombinant Proteins; Silver Staining; tau Proteins; Time Factors | 1999 |